Anti-Inflammatory Enzymes and Enzyme Feed Additives | Pearlzyme Inc
Pearlzyme Inc. develops and manufactures environmentally friendly products using useful natural microorganisms and unique enzymes.
Pearlzyme Inc. develops and manufactures environmentally friendly products using useful natural microorganisms and unique enzymes. They are an R&D-driven company with a focus on anti-inflammatory, anti-allergic, and immune-boosting effects.PEARLZYME® uses anti-inflammatory enzymes and enzyme feed additives to strengthen the animal's immune system and improve milk lactation.
"PEARLZYME®" is a strong protease produced by microorganisms (Bacillus sp.) that flourish in the harsh and extreme settings of mudflats on Korea's West Coast. The extremophile-derived "PEARLZYME®" has robust proteolytic activity at high temperatures, a wide pH range, and high salt concentrations. Additionally, it has anti-inflammatory and anti-autoimmune effects.
PEARLZYME® anti-inflammatory feed additive
PEARLZYME® is used in a wide range of livestock, including cattle, pigs, poultry, and fish. It is effective for treating a wide range of inflammatory disorders, including mastitis, diarrhea, and respiratory infections. PEARLZYME® can also be used to prevent inflammation and boost animal health and performance.
PEARLZYME® is a safe and effective product that can help improve animal health and performance. It is a natural product that contains no antibiotics or other potentially dangerous substances.
If you're seeking a natural way to boost your livestock's health and performance, the PEARLZYME® anti-inflammatory feed additive is worth considering.
Click hereto contact Pearlzyme Inc.
View more: Anti-Inflammatory Enzymes and Enzyme Feed Additives.
- Contact Email
- [email protected]
- Issued By
- Pearlzyme Inc.
- Country
- Korea, Republic of
- Categories
- Business
- Last Updated
- April 24, 2024
Disclaimer: This press release was submitted by a registered PRFree contributor and has not been verified or endorsed by PRFree. PRFree assumes no responsibility or liability for its accuracy, content, legality, or reliability. The contact email for this release can be viewed here. See our Disclaimer.